Valdoxan (agomelatine) in the Treatment of Depression in Cerebrovascular Diseases (results of the Russian Resonance multicenter naturalistic study)

By Pizova N.  

Neuroscience and Behavioral Physiology, Vol. 44, Iss. 3, 2014-03 ,pp. : 315-319

Springer Publishing Company

Access to resources Recommend Favorite

Use of Valdoxan (Agomelatin) in the Combined Treatment of Moderate and Severe Nonpsychotic Depression

By Medvedev V.  

Neuroscience and Behavioral Physiology, Vol. 43, Iss. 7, 2013-09 ,pp. : 878-882

Springer Publishing Company

Access to resources Recommend Favorite

A randomized controlled trial to improve the recognition, diagnosis and treatment of major depression in elderly people in general practice: design, first results and feasibility of the West Friesland Study

By Bijl D.   van Marwijk H. W. J.   Beekman A. T. F.   de Haan M.   van Tilburg W.  

Primary Care Psychiatry, Vol. 8, Iss. 4, 2003-08 ,pp. : 135-140

Informa Healthcare

Access to resources Recommend Favorite

Experience with risperidone long-acting injection: results of a naturalistic observation study

By Deslandes Paul   Thomas Arwel   Faulconbridge Gwawr   Davies Wendy  

International Journal of Psychiatry in Clinical Practice, Vol. 11, Iss. 3, 2007-01 ,pp. : 207-211

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Long-term, naturalistic treatment with olanzapine, risperidone, quetiapine, or haloperidol monotherapy: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study

By Lee Phil   Eung Kim Chul   Yoon Kim Chang   Lin Wei-Wen   Habil Hussain   Dyachkova Yulia   Mcbride Margaret   Dossenbach Martin  

International Journal of Psychiatry in Clinical Practice, Vol. 12, Iss. 3, 2008-01 ,pp. : 215-227

Ashgate Publishing Ltd

Access to resources Recommend Favorite